PATENT CLAIM ANALYSIS

Application Number: 16061092
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["549", "285000"]

Abstract:
Disclosed is a configurational stereoisomer, referred to as enantiomer E 2 , of flocoumafen, the enantiomer E 2  having, as determined by the chromatographic analysis of a flocoumafen composition including four configurational stereoisomers of flocoumafen, carried out under conditions described hereinafter, a retention time t 2  with a value such that t 1 <t 2 <t 3 <t 4 ; t 1 , t 3  and t 4  representing the retention times of the configurational stereoisomers of flocoumafen different from the enantiomer E 2 , the chromatographic analysis being carried out at a temperature of 23.5° C.

Claim (Index 13):
Composition comprising a configurational stereoisomer, named enantiomer E 2 , of flocoumafen, with the exclusion of a racemic mixture of said enantiomer E 2  and of a configurational stereoisomer, named enantiomer E 3 , of flocoumafen;\n said enantiomer E 2  having, by chromatographic analysis of a flocoumafen composition comprising four configurational stereoisomers of flocoumafen performed under the conditions described below, a retention time t 2 ; said enantiomer E 3  having, by analysis of flocoumafen comprising four configurational stereoisomers of flocoumafen performed under these same conditions, a retention time t 3 ; t 2  and t 3  being values such that t 1 <t 2 <t 3 <t 4 ; t 1  and t 4  representing the retention times of each of the configurational stereoisomers of flocoumafen different from said enantiomer E 2  and from said enantiomer E 3 , the chromatographic analysis being performed at a temperature of 23.5\u00b0 C. and under the following conditions:\n on a high-pressure liquid chromatography column of dimensions 150\u00d72 mm, and comprising a chiral stationary phase constituted of particles of tris(4-chloro-3-methylphenyl carbamate) cellulose, said particles having a mean size of 3 \u03bcm and having a mean pore size of 1000 \u212b; \n using, as liquid mobile phase, a mixture formed from acetonitrile (A) and water comprising 0.1% by volume of formic acid (B), with an A/B volume ratio of 92/8 and with a flow rate of the liquid mobile phase in the chromatography column of 0.25 mL/minute; \n by injection into the chromatography column of a volume of 1 \u03bcL of flocoumafen composition at a concentration of 1 \u03bcg of flocoumafen per millilitre of acetonitrile.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 94.0
- Lexical Diversity: 2.0
- Patent Class: 549.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['16061115', '16061084', '15735677', '15318123', '15318195']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.761490738292966
- 35 USC 102 Novelty (BERT): 0.6213270965555762
- Combined Prediction Score: 0.747474374119227
- Mean Citation Score: 417.5201
- Max Citation Score: 622.0921
- Similarity Product: 509.6104195302426

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test